| Nanoparticle hydrophobicity dictates immune response DF Moyano, M Goldsmith, DJ Solfiell, D Landesman-Milo, OR Miranda, ... Journal of the American Chemical Society 134 (9), 3965-3967, 2012 | 518 | 2012 |
| A modular platform for targeted RNAi therapeutics R Kedmi, N Veiga, S Ramishetti, M Goldsmith, D Rosenblum, N Dammes, ... Nature nanotechnology 13 (3), 214-219, 2018 | 295 | 2018 |
| Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes N Veiga, M Goldsmith, Y Granot, D Rosenblum, N Dammes, R Kedmi, ... Nature communications 9 (1), 4493, 2018 | 284 | 2018 |
| Systemic gene silencing in primary T lymphocytes using targeted lipid nanoparticles S Ramishetti, R Kedmi, M Goldsmith, F Leonard, AG Sprague, B Godin, ... ACS nano 9 (7), 6706-6716, 2015 | 192 | 2015 |
| Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles ZR Cohen, S Ramishetti, N Peshes-Yaloz, M Goldsmith, A Wohl, Z Zibly, ... ACS nano 9 (2), 1581-1591, 2015 | 185 | 2015 |
| Conformation-sensitive targeting of lipid nanoparticles for RNA therapeutics N Dammes, M Goldsmith, S Ramishetti, JLJ Dearling, N Veiga, ... Nature nanotechnology 16 (9), 1030-1038, 2021 | 120 | 2021 |
| Precision nanomedicine in neurodegenerative diseases M Goldsmith, L Abramovitz, D Peer ACS nano 8 (3), 1958-1965, 2014 | 117 | 2014 |
| Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies S Weinstein, IA Toker, R Emmanuel, S Ramishetti, I Hazan-Halevy, ... Proceedings of the National Academy of Sciences 113 (1), E16-E22, 2016 | 107 | 2016 |
| Hyaluronan grafted lipid-based nanoparticles as RNAi carriers for cancer cells D Landesman-Milo, M Goldsmith, SL Ben-Arye, B Witenberg, E Brown, ... Cancer letters 334 (2), 221-227, 2013 | 88 | 2013 |
| Tumor targeting profiling of hyaluronan-coated lipid based-nanoparticles S Mizrahy, M Goldsmith, S Leviatan-Ben-Arye, E Kisin-Finfer, O Redy, ... Nanoscale 6 (7), 3742-3752, 2014 | 79 | 2014 |
| Bioinspired artificial exosomes based on lipid nanoparticles carrying let-7b-5p promote angiogenesis in vitro and in vivo S Aday, I Hazan-Halevy, A Chamorro-Jorganes, M Anwar, M Goldsmith, ... Molecular Therapy 29 (7), 2239-2252, 2021 | 65 | 2021 |
| Leukocyte-specific siRNA delivery revealing IRF8 as a potential anti-inflammatory target N Veiga, M Goldsmith, Y Diesendruck, S Ramishetti, D Rosenblum, ... Journal of Controlled Release 313, 33-41, 2019 | 58 | 2019 |
| A Combinatorial Library of Lipid Nanoparticles for Cell Type‐Specific mRNA Delivery GS Naidu, SB Yong, S Ramishetti, R Rampado, P Sharma, A Ezra, ... Advanced Science 10 (19), 2301929, 2023 | 57 | 2023 |
| A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium E Kon, Y Levy, U Elia, H Cohen, I Hazan-Halevy, M Aftalion, A Ezra, ... Science Advances 9 (10), eadg1036, 2023 | 52 | 2023 |
| Dual‐targeted lipid nanotherapeutic boost for chemo‐immunotherapy of cancer SB Yong, S Ramishetti, M Goldsmith, Y Diesendruck, I Hazan‐Halevy, ... Advanced Materials 34 (13), 2106350, 2022 | 48 | 2022 |
| Comprehensive and systematic analysis of the immunocompatibility of polyelectrolyte capsules MV Zyuzin, P Díez, M Goldsmith, S Carregal-Romero, C Teodosio, ... Bioconjugate chemistry 28 (2), 556-564, 2017 | 46 | 2017 |
| Synergistic IL-10 induction by LPS and the ceramide-1-phosphate analog PCERA-1 is mediated by the cAMP and p38 MAP kinase pathways M Goldsmith, D Avni, O Ernst, Y Glucksam, G Levy-Rimler, MM Meijler, ... Molecular immunology 46 (10), 1979-1987, 2009 | 44 | 2009 |
| Grand challenges in modulating the immune response with RNAi nanomedicines M Goldsmith, S Mizrahy, D Peer Nanomedicine 6 (10), 1771-1785, 2011 | 42 | 2011 |
| A ceramide‐1‐phosphate analogue, PCERA‐1, simultaneously suppresses tumour necrosis factor‐α and induces interleukin‐10 production in activated macrophages M Goldsmith, D Avni, G Levy‐Rimler, R Mashiach, O Ernst, M Levi, ... Immunology 127 (1), 103-115, 2009 | 41 | 2009 |
| Therapeutic gene silencing using targeted lipid nanoparticles in metastatic ovarian cancer MS Singh, S Ramishetti, D Landesman‐Milo, M Goldsmith, S Chatterjee, ... Small 17 (19), 2100287, 2021 | 40 | 2021 |
